BRII-179, BRII-835 (VIR-2218), PEG-IFNα — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BR
Phase 2 · For Treatment of Chronic Hepatitis B Virus Infection |
Brii Biosciences Limited | BRII-179, BRII-835 (VIR-2218), PEG-IFNα |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|